Edition:
United Kingdom

People: Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

5.58USD
5:52pm BST
Change (% chg)

$0.06 (+1.09%)
Prev Close
$5.52
Open
$5.53
Day's High
$5.75
Day's Low
$5.41
Volume
99,828
Avg. Vol
186,663
52-wk High
$21.31
52-wk Low
$5.04

Walker, Neal 

Dr. Neal Walker is President, Chief Executive Officer and Director of Aclaris Therapeutics, Inc. Dr. Walker co-founded NeXeption, LLC in August 2012. Between July 2011 and July 2012, Dr. Walker served as a consultant to a number of pharmaceutical companies. Dr. Walker co-founded and served as President and Chief Executive Officer and a member of the board of directors of Vicept Therapeutics, Inc., a dermatology-focused specialty pharmaceutical company, from 2009 until its acquisition by Allergan, Inc. in July 2011. Previously, Dr. Walker co-founded and led a number of life science companies, including Octagon Research Solutions, Inc., a software and services provider to biopharmaceutical companies (acquired by Accenture plc), Trigenesis Therapeutics, Inc., a specialty dermatology company, where he served as Chief Medical Officer (acquired by Dr. Reddy’s Laboratories Inc.), and Cutix Inc., a commercial dermatology company. He began his pharmaceutical industry career at Johnson and Johnson, Inc. Dr. Walker is a director of Alderya Therapeutics, Inc., a publicly held biotechnology company, as well as several private biotechnology companies. Dr. Walker received his M.B.A. degree from The Wharton School, University of Pennsylvania, his Doctor of Osteopathic Medicine degree from the Philadelphia College of Osteopathic Medicine and a B.A. degree in Biology from Lehigh University. Dr. Walker’s experience as a board-certified dermatologist and the founder of our company and other pharmaceutical companies, his background in clinical and product development in dermatology and other fields, and his knowledge of the pharmaceutical industry contributed to the conclusion of our Board that he should serve as a director of our company. Dr. Walker co-founded NeXeption, LLC in August 2012. Between July 2011 and July 2012, Dr. Walker served as a consultant to a number of pharmaceutical companies. Dr. Walker co-founded and served as President and Chief Executive Officer and a member of the board of directors of Vicept Therapeutics, I

Basic Compensation

Total Annual Compensation, USD 510,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 299,586
Fiscal Year Total, USD 809,586

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --